Smartlab Europe

Press Releases

Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation  

Amgen and Array BioPharma announced a collaboration agreement for the discovery and development of novel drugs for autoimmune disorders.  The undisclosed target and lead inhibitors were discovered through Array's proprietary platform that leverages Array's expertise in...

Clinerion And Cisiv Team Up For Leading Innovation In Real World Research 

Two industry innovators are joining forces to take the lead in real-world studies. Clinerion and Cisiv have formed a groundbreaking partnership to offer a revolutionary approach to observational research by enabling automated data transfer from electronic hospital records (EHRs)...

Specialist CRO expands pharmacovigilance capabilities

Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform in preparation for the upcoming Article 2(3) of Directive 2010/84/EU that will impact the pharmaceutical industry later this year. ...

The region’s leading healthcare exhibition sold out!

MEDICAL FAIR THAILAND 2017 will be its largest edition yet, with booth space fully sold out since May, featuring 700 exhibitors from 45 countries including 18 National Pavilions and country groups on a show floor that has expanded by 20% compared to...

Vitafoods Asia Elevates 2017 Learning Programme

Vitafoods Asia, the only event dedicated to the nutraceutical, functional food and beverages, and dietary supplement industries in Asia, announces the agenda for its 2017 Conference Programme. Now into its seventh edition, the highly-anticipated industry event...

Eisai Submits Application for Additional Indication of Anticancer Agent Lenvima for Hepatocellular Carcinoma in Japan

Eisai Co., Ltd. announced that it has submitted an application for an additional indication of its in-house discovered and developed anticancer agent Lenvima (generic name: lenvatinib mesylate) for the treatment of hepatocellular carcinoma (HCC) in Japan, the first in...

New Single Quadrupole Mass Spectrometer and Specialized Columns Designed to Deliver Reproducible and Robust Separations, Increase Analytical Accuracy

Thermo Fisher Scientific Inc., the world leader in serving science, announced new technologies that are designed to allow analytical chemists to obtain high-resolution separations with outstanding sensitivity and reproducibility.  Visitors can learn about these and other...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »